
Semax is a synthetic heptapeptide analog of a fragment of the adrenocorticotropic hormone (ACTH 4-10). It is highly regarded in the neuroscientific community for its potent neuroprotective and nootropic properties. In research settings, it is primarily studied for its ability to cross the blood-brain barrier and modulate the expression of neurotrophins, making it a cornerstone for investigating cognitive enhancement, neuroregeneration, and the treatment of cerebrovascular disorders in preclinical models.